Akme Fintrade (India) Limited has informed the exchange regarding the receipt of trading approval for 82,00,000 Equity Shares having face value of Rs.1/- (Rupees One Only) each allotted pursuant to conversion of warrants in accordance with SEBI (ICDR) Regulations, 2018.

Date: October 30, 2026 National Stock Exchange of BSE Limited India Limited (NSE) Phiroze JeejeeBhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400001. Bandra, Mumbai – 400051. Scrip Code: 544200 Symbol: AFIL Subject: Intimation of trading approval received for 82,00,000 (Eighty-Two Lakh) Equity Shares having Face value of Rs. 1/- (Rupees One only) each allotted pursuant to conversion of warrants issued on preferential basis in terms or Chapter V or SEBI (ICDR) Regulations. 2018. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) ("SEBI Listing Regulations") read with Schedule [11 of the SEBI Listing Regulations and clause 12 of Para B of Annexure 18 of SEBI Master Circular No. dated January 30, 2026, as amended from time to time, we would like to inform you that the Company has received trading approval from National Stock Exchange of India Limited and BSE Limited for 82,00,000 (Eighty-Two Lakh) Equity Shares having face value of Rs. 1/- (Rupees One only) each allotted pursuant to conversion of warrants to Promoter and Non-Promoter on preferential basis in terms of Chapter V of SEBI (ICDR) Regulations, 2018. The trading approval letters received from National Stock Exchange of India Limited and BSE Limited dated October 29, 2026 are enclosed herewith. We request you to take the same on your record. Relevant Details as required pursuant to Regulation 30 of the SEBI Listing Regulations read with clause 12 of para B of Annexure 18 of SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are under Annexure A. Kindly take the same on record. Thanking You, Yours Truly, For Akme Fintrade (India) Limited Manoj Kumar Choubisa Company Secretary and Compliance Officer M. No.: A66176 Annexure A Relevant Details as required pursuant to Regulation 30 of the SEBI Listing Regulations read with clause 12 of para B of Annexure 18 of SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Sr. No. Particulars Description 1. Name of the regulatory or licensing authority National Stock Exchange of India Limited ("NSE") & BSE Limited ("BSE"). 2. Brief details of the approval/license obtained/ withdrawn/ Trading approval granted for surrendered 82,00,000 (Eighty-Two Lakh) Equity Shares of Rs. 1/- (Rupees One Only) each allotted to Promoter and Non- Promoter on preferential basis. 3. Impact/relevance of such approval/license to the listed entity Upon receipt of trading approvals, the listed capital of the Company increased to Rs. 44,79,49,960 (44,79,49,960 fully paid Equity Shares of Rs. 1/- each). 4. Withdrawal/cancellation or suspension of licence 'approval by the Not Applicable. regulatory or licensing authority, with reasons for such action, estimated impact (monetary or otherwise) on the listed entity and penalty, If any 5. Period for which such approval/license is/was valid As per the relevant applicable provisions. 6 Subsequently, the listed entity shall inform the stock exchange(s), Not Applicable. the actual impact (monetary or otherwise) along with corrective actions taken by the listed entity pursuant to the withdrawal, cancellation or suspension of the key license/approval